Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

Press releases published on October 27, 2026

Oct. 27, 2026

Checkmarx Wins Cyber Defense Magazine’s Editor’s Choice GenAI Agentic Application Security Award

Indeterminate GlobeNewswire

Oct. 27, 2026

Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments

Indeterminate GlobeNewswire

Oct. 27, 2026

Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Indeterminate GlobeNewswire

Oct. 27, 2026

Critical Metals Corp. Acquisition of European Lithium Becomes Effective

Indeterminate GlobeNewswire

Oct. 27, 2026

Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

Indeterminate GlobeNewswire

Oct. 27, 2026

Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial

Indeterminate GlobeNewswire

Oct. 27, 2026

Nexera Technologies Signs Definitive Agreement to Sell KeepZone AI to a Global Aerospace and Defense Company for up to $6 million

Indeterminate GlobeNewswire

Oct. 27, 2026

Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker

Indeterminate GlobeNewswire

Oct. 27, 2026

Allot to Release Third Quarter 2026 Results and Host Conference Call on November 12, 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline

Indeterminate GlobeNewswire

Oct. 27, 2026

AssistRx Named a Central Florida Top Workplace for Sixth Consecutive Year

Indeterminate GlobeNewswire

Oct. 27, 2026

Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors

Indeterminate GlobeNewswire

Oct. 27, 2026

CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union

Indeterminate GlobeNewswire

Oct. 27, 2026

Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution

Indeterminate GlobeNewswire

Oct. 27, 2026

Humanitas Global Health Announces Launch and LSU DeepDrug License Agreement at AAPS PharmSci 360

Indeterminate GlobeNewswire

Oct. 27, 2026

Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering

Indeterminate GlobeNewswire

Oct. 27, 2026

Terra Balcanica Spin Off Terra North Resources Confirms Multiple Uranium Targets over Charlot-Neely Lake Claims North of Athabasca Basin, Saskatchewan

Indeterminate GlobeNewswire

Oct. 27, 2026

Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal

Indeterminate GlobeNewswire

Oct. 27, 2026

Dynacor Group Announces November 2026 Dividend

Indeterminate GlobeNewswire